Listeria

Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)
Raffit Hassan, Evan Alley, Hedy Kindler, Scott Antonia, Thierry Jahan, Anish Thomas, Somayeh Honarmand, Aimee L Murphy, John J Grous, Dirk G Brockstedt

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P161; DOI: 10.1186/2051-1426-3-S2-P161
Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)
Dung T Le, Todd S Crocenzi, Jennifer N Urum, Eric R Lutz, Daniel A Laheru, Elizabeth A Sugar, Robert H Vonderheide, George A Fisher, Andrew H Ko, Aimee L Murphy, Katherine McDougall, Sandy Ferber, Dirk G Brockstedt, Elizabeth M Jaffee

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P155; DOI: 10.1186/2051-1426-3-S2-P155
Phase I/II study of ADXS11-001 or MEDI4736 immunotherapies alone and in combination, in patients with recurrent/metastatic cervical or human papillomavirus (HPV)-positive head and neck cancer
Ezra EW Cohen, Kathleen N Moore, Brian M Slomovitz, Christine H Chung, Matthew L Anderson, Shannon R Morris, David Mauro, Barbara Burtness

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P147; DOI: 10.1186/2051-1426-3-S2-P147
Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas
Marka Crittenden, Keith S Bahjat, Rui Li, Pankaj Gore, Chris Fountain, Bill Hanson, Justin Skoble, Peter Lauer, Aimee L Murphy, Thomas Dubensky, Dirk G Brockstedt, Walter Urba

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P162; DOI: 10.1186/2051-1426-3-S2-P162
Radiation therapy and vaccination against tumor-specific EGFRvIII effectively clears tumors in a murine model of head and neck squamous cell carcinoma
Lauren Uhde, Shelly Bambina, Alejandro Alice, Peter Lauer, Marka Crittenden, Keith S Bahjat, Michael Gough

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P78; DOI: 10.1186/2051-1426-3-S2-P78
Biomarker identification in serum samples from patients with recurrent cervical cancer treated with ADXS11-001 immunotherapy
Poonam Molli, Inga Malinina, Anu Wallecha

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P61; DOI: 10.1186/2051-1426-1-S1-P61
Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment
Anu Wallecha, Inga Malinina, Poonam Molli

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) O18; DOI: 10.1186/2051-1426-1-S1-O18
High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
Sharad Ghamande, David Mauro, Cheryl Price, Donna Wheatley, John Janik, Samir N Khleif

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P151; DOI: 10.1186/2051-1426-3-S2-P151

Log in using your username and password

Main menu

Log in using your username and password

You are here

Listeria